A US appeals court docket has present in favor of Masimo in its combat in opposition to Apple over pulse oximetry patents, however within the court docket that issues, a ruling makes it clear that there will not be one other ban on the Apple Watch.
Within the now six year-long authorized battle between medical know-how agency Masimo and Apple, this explicit enchantment considerations a ruling by the Worldwide Commerce Fee (ITC). The ITC dominated that Apple had stolen commerce secrets and techniques and violated patents with its blood pulse oximeter within the Apple Watch.
Masimo wished a ban on the Apple Watch and in October 2023, the ITC issued an order barring Apple from importing the Apple Watch into the US, and in December denied the corporate’s enchantment in opposition to it.
Now as first noticed by IP Fray, the US Court docket of Enchantment for the Federal Circuit has backed the unique ITC ruling. The textual content of the court docket submitting is a single sentence saying that the ruling has been affirmed, and offers no rationalization for this conclusion.
The itemizing for this submitting says slightly extra, that the enchantment was “terminated on the deserves after oral argument.” Apple can be required to pay prices.
Nevertheless, this ruling on March 19, 2026, adopted a ruling by the US Worldwide Commerce Fee (ITC) the day earlier than. That submitting, presumably written figuring out the appeals court docket’s resolution, states that Apple doesn’t now must do something extra to treatment the case.
Itemizing every of the particular patents named within the numerous instances, the ITC says it finds that Apple doesn’t infringe any of them. It repeatedly refers to what it calls the “Apple Redesign 2 Watch,” presumably that means that Apple’s software program replace eliminated the claimed infringements.
“We thank the Administrative Regulation Choose for her cautious consideration, and are happy with the choice,” Apple advised AppleInsider and sure different venues as nicely. “For six years, Masimo has introduced dozens of false claims in opposition to Apple, practically all of which have been rejected. We’ll proceed innovating to create industry-leading well being, wellness, and life-saving options for our customers.”
How we bought right here
The unique lawsuit was filed with the US District Court docket for the Central District of California by Masimo in 2020. It was then adopted in 2021 by Masimo’s criticism to the ITC.
By 2023, the preliminary lawsuit had ended with a mistrial after jurors couldn’t attain a unanimous verdict. However this separate ITC case was received by Masimo in January 2023.
The rear sensor of the Apple Watch Sequence 9 with its well being senors
The ITC really helpful a ban on the US import of any Apple Watch fashions that violated Masimo’s patents. The advice triggered a 60-day evaluation interval inside the White Home, which may have determined in opposition to the ban — however did not.
With the ban then sure to come back into have an effect on for the Apple Watch Sequence 6 and later, Apple stopped importing and promoting the affected fashions forward of the ban going down.
On the similar time, nevertheless, Apple labored on the thought of a software program replace to avoid the allegedly patent-violating function. The replace primarily simply disabled the blood oxygen function, which the US Customs and Border Safety company determined in January 2024 was ample.
In November 2025, Masimo received a $634 million verdict in a federal jury trial. That ruling has not been affected by the brand new filings, and Masimo referred to as it “a big win in our ongoing efforts to guard our improvements and mental property.”
For its half, Apple advised AppleInsider that the November 2025 resolution was “opposite to the information.” It claimed that “Masimo is a medical machine firm that doesn’t promote any merchandise to customers.”
“We plan to enchantment,” concluded Apple.
So whatever the newest resolution relating to the enchantment, the authorized battle between the 2 firms is about to proceed. Nevertheless, they’ve now been in dispute lengthy sufficient that patents in query might expire inside lower than three years, permitting Apple to renew utilizing its function.